{
  "guideline": {
    "id": "PA166264961",
    "name": "Annotation of DPWG Guideline for allopurinol and ABCG2",
    "source": "DPWG",
    "version": 9,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166264961",
    "relatedChemicals": [
      {
        "id": "PA448320",
        "name": "allopurinol",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA390",
        "name": "ATP binding cassette subfamily G member 2 (Junior blood group)",
        "symbol": "ABCG2"
      }
    ],
    "recommendation": true,
    "guidelineGenes": [
      {
        "alleles": [
          {
            "id": 1451699242,
            "_label": "c.421 G (141Q)",
            "function": {
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335"
            }
          },
          {
            "id": 1451699241,
            "_label": "c.421 T (141K)",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          }
        ],
        "gene": {
          "chr": {
            "id": "PA529",
            "name": "chr4",
            "symbol": null
          },
          "strand": "minus",
          "id": "PA390",
          "name": "ATP binding cassette subfamily G member 2 (Junior blood group)",
          "symbol": "ABCG2"
        }
      }
    ]
  },
  "annotationGroups": [
    {
      "id": "PA166264962",
      "name": "Normal function",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "ABCG2:Normal function/Normal function"
      ],
      "metabolizerStatus": null,
      "recommendation": {
        "id": 1451699268,
        "html": "<p>The guideline does not provide a recommendation for allopurinol in patients with the the ABCG2 c.421 GG genotype.</p>\n"
      },
      "implications": {
        "id": 1451699266,
        "html": "<p>The guideline does not provide a description of the impact of the ABCG2 c.421 GG genotype on allopurinol.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166264963",
      "name": "Decreased function GT",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "Yes",
        "termId": "rxChange:1448602497"
      },
      "genePhenotypes": [
        "ABCG2:Decreased function/Normal function"
      ],
      "metabolizerStatus": null,
      "recommendation": {
        "id": 1451699271,
        "html": "<p>Use 1.25 times the standard dose.<br />\nThis equates to a dose titration schedule of 100, 200, 400 and 500 mg/day instead of the usual schedule of 100, 200, 300 and 400 mg/day.</p>\n"
      },
      "implications": {
        "id": 1451699269,
        "html": "<p>The effectiveness of allopurinol is reduced, meaning that a higher dose is required. The gene variation reduces the excretion of uric acid by kidneys and intestines, meaning that a stronger inhibition of the uric acid production by allopurinol is required to achieve the desired uric acid concentration.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166264964",
      "name": "Decreased function TT",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "Yes",
        "termId": "rxChange:1448602497"
      },
      "genePhenotypes": [
        "ABCG2:Decreased function/Decreased function"
      ],
      "metabolizerStatus": null,
      "recommendation": {
        "id": 1451699265,
        "html": "<p>Use 1.4 times the standard dose.<br />\nThis equates to a dose titration schedule of 100, 300, 400, 600 and 700 mg/day instead of the usual schedule of 100, 200, 300, 400 and 500 mg/day.</p>\n"
      },
      "implications": {
        "id": 1451699263,
        "html": "<p>The effectiveness of allopurinol is reduced, meaning that a higher dose is required. The gene variation reduces the excretion of uric acid by kidneys and intestines, meaning that a stronger inhibition of the uric acid production by allopurinol is required to achieve the desired uric acid concentration.</p>\n"
      },
      "activityScore": null
    }
  ],
  "citations": [
    {
      "pmid": "36056234",
      "title": "Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate.",
      "authors": [
        "van der Pol Karel H",
        "Nijenhuis Marga",
        "Soree Bianca",
        "de Boer-Veger Nienke J",
        "Buunk Anne Marie",
        "Guchelaar Henk-Jan",
        "Risselada Arne",
        "van Schaik Ron H N",
        "Swen Jesse J",
        "Touw Daan",
        "van der Weide Jan",
        "van Westrhenen Roos",
        "Deneer Vera H M",
        "Houwink Elisa J F",
        "Rongen Gerard A"
      ],
      "journal": "European journal of human genetics : EJHG",
      "year": 2022
    }
  ]
}